Selected research
Industry Research
Immunochromogenic Kit Industry Research Report 2026
Market perspective
The global Immunochromogenic Kit market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Immunochromogenic Kit is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Immunochromogenic Kit is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Immunochromogenic Kit is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Immunochromogenic Kit include Abbott Laboratories, Beckman Coulter, Becton, Dickinson and Company, BioMérieux, Bio-Rad Laboratories, PerkinElmer, Qiagen, Roche Diagnostics and Siemens Healthineers, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Immunochromogenic Kit market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Immunochromogenic Kit Market by Company
Abbott Laboratories
Beckman Coulter
Becton, Dickinson and Company
BioMérieux
Bio-Rad Laboratories
PerkinElmer
Qiagen
Roche Diagnostics
Siemens Healthineers
Lonza Group
Randox Laboratories
EKF Diagnostics
BaiO Technology
Immunochromogenic Kit Segment by Type
Tumor Marker Detection Kit
Infectious Disease Detection Kit
Other
Immunochromogenic Kit Segment by Application
Medical Diagnostics
Food Safety Testing
Environmental Monitoring
Research
Immunochromogenic Kit Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunochromogenic Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immunochromogenic Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunochromogenic Kit.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Immunochromogenic Kit manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Immunochromogenic Kit by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Immunochromogenic Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tumor Marker Detection Kit
- Infectious Disease Detection Kit
- Other
Applications
- Medical Diagnostics
- Food Safety Testing
- Environmental Monitoring
- Research
Companies covered
- Abbott Laboratories
- Beckman Coulter
- Becton, Dickinson and Company
- BioMérieux
- Bio-Rad Laboratories
- PerkinElmer
- Qiagen
- Roche Diagnostics
- Siemens Healthineers
- Lonza Group
- Randox Laboratories
- EKF Diagnostics
- BaiO Technology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Immunochromogenic Kit Market Size (2021-2032)
- 2.2.2 Global Immunochromogenic Kit Sales (2021-2032)
- 2.2.3 Global Immunochromogenic Kit Market Average Price (2021-2032)
- 2.3 Immunochromogenic Kit by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tumor Marker Detection Kit
- 2.3.3 Infectious Disease Detection Kit
- 2.3.4 Other
- 2.4 Immunochromogenic Kit by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Medical Diagnostics
- 2.4.3 Food Safety Testing
- 2.4.4 Environmental Monitoring
- 2.4.5 Research
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Immunochromogenic Kit Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Immunochromogenic Kit Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Immunochromogenic Kit Revenue of Manufacturers (2021-2026)
- 3.4 Global Immunochromogenic Kit Average Price by Manufacturers (2021-2026)
- 3.5 Global Immunochromogenic Kit Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Immunochromogenic Kit, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Immunochromogenic Kit, Product Type & Application
- 3.8 Global Manufacturers of Immunochromogenic Kit, Established Date
- 3.9 Global Immunochromogenic Kit Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott Laboratories
- 4.1.1 Abbott Laboratories Company Information
- 4.1.2 Abbott Laboratories Business Overview
- 4.1.3 Abbott Laboratories Immunochromogenic Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Laboratories Immunochromogenic Kit Product Portfolio
- 4.1.5 Abbott Laboratories Recent Developments
- 4.2 Beckman Coulter
- 4.2.1 Beckman Coulter Company Information
- 4.2.2 Beckman Coulter Business Overview
- 4.2.3 Beckman Coulter Immunochromogenic Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Beckman Coulter Immunochromogenic Kit Product Portfolio
- 4.2.5 Beckman Coulter Recent Developments
- 4.3 Becton, Dickinson and Company
- 4.3.1 Becton, Dickinson and Company Company Information
- 4.3.2 Becton, Dickinson and Company Business Overview
- 4.3.3 Becton, Dickinson and Company Immunochromogenic Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Becton, Dickinson and Company Immunochromogenic Kit Product Portfolio
- 4.3.5 Becton, Dickinson and Company Recent Developments
- 4.4 BioMérieux
- 4.4.1 BioMérieux Company Information
- 4.4.2 BioMérieux Business Overview
- 4.4.3 BioMérieux Immunochromogenic Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 BioMérieux Immunochromogenic Kit Product Portfolio
- 4.4.5 BioMérieux Recent Developments
- 4.5 Bio-Rad Laboratories
- 4.5.1 Bio-Rad Laboratories Company Information
- 4.5.2 Bio-Rad Laboratories Business Overview
- 4.5.3 Bio-Rad Laboratories Immunochromogenic Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bio-Rad Laboratories Immunochromogenic Kit Product Portfolio
- 4.5.5 Bio-Rad Laboratories Recent Developments
- 4.6 PerkinElmer
- 4.6.1 PerkinElmer Company Information
- 4.6.2 PerkinElmer Business Overview
- 4.6.3 PerkinElmer Immunochromogenic Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 PerkinElmer Immunochromogenic Kit Product Portfolio
- 4.6.5 PerkinElmer Recent Developments
- 4.7 Qiagen
- 4.7.1 Qiagen Company Information
- 4.7.2 Qiagen Business Overview
- 4.7.3 Qiagen Immunochromogenic Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Qiagen Immunochromogenic Kit Product Portfolio
- 4.7.5 Qiagen Recent Developments
- 4.8 Roche Diagnostics
- 4.8.1 Roche Diagnostics Company Information
- 4.8.2 Roche Diagnostics Business Overview
- 4.8.3 Roche Diagnostics Immunochromogenic Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Roche Diagnostics Immunochromogenic Kit Product Portfolio
- 4.8.5 Roche Diagnostics Recent Developments
- 4.9 Siemens Healthineers
- 4.9.1 Siemens Healthineers Company Information
- 4.9.2 Siemens Healthineers Business Overview
- 4.9.3 Siemens Healthineers Immunochromogenic Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Siemens Healthineers Immunochromogenic Kit Product Portfolio
- 4.9.5 Siemens Healthineers Recent Developments
- 4.10 Lonza Group
- 4.10.1 Lonza Group Company Information
- 4.10.2 Lonza Group Business Overview
- 4.10.3 Lonza Group Immunochromogenic Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Lonza Group Immunochromogenic Kit Product Portfolio
- 4.10.5 Lonza Group Recent Developments
- 4.11 Randox Laboratories
- 4.11.1 Randox Laboratories Company Information
- 4.11.2 Randox Laboratories Business Overview
- 4.11.3 Randox Laboratories Immunochromogenic Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Randox Laboratories Immunochromogenic Kit Product Portfolio
- 4.11.5 Randox Laboratories Recent Developments
- 4.12 EKF Diagnostics
- 4.12.1 EKF Diagnostics Company Information
- 4.12.2 EKF Diagnostics Business Overview
- 4.12.3 EKF Diagnostics Immunochromogenic Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 EKF Diagnostics Immunochromogenic Kit Product Portfolio
- 4.12.5 EKF Diagnostics Recent Developments
- 4.13 BaiO Technology
- 4.13.1 BaiO Technology Company Information
- 4.13.2 BaiO Technology Business Overview
- 4.13.3 BaiO Technology Immunochromogenic Kit Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 BaiO Technology Immunochromogenic Kit Product Portfolio
- 4.13.5 BaiO Technology Recent Developments
5 Global Immunochromogenic Kit Market Scenario by Region
- 5.1 Global Immunochromogenic Kit Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Immunochromogenic Kit Sales by Region: 2021-2032
- 5.2.1 Global Immunochromogenic Kit Sales by Region: 2021-2026
- 5.2.2 Global Immunochromogenic Kit Sales by Region: 2027-2032
- 5.3 Global Immunochromogenic Kit Revenue by Region: 2021-2032
- 5.3.1 Global Immunochromogenic Kit Revenue by Region: 2021-2026
- 5.3.2 Global Immunochromogenic Kit Revenue by Region: 2027-2032
- 5.4 North America Immunochromogenic Kit Market Facts & Figures by Country
- 5.4.1 North America Immunochromogenic Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Immunochromogenic Kit Sales by Country (2021-2032)
- 5.4.3 North America Immunochromogenic Kit Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Immunochromogenic Kit Market Facts & Figures by Country
- 5.5.1 Europe Immunochromogenic Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Immunochromogenic Kit Sales by Country (2021-2032)
- 5.5.3 Europe Immunochromogenic Kit Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Immunochromogenic Kit Market Facts & Figures by Country
- 5.6.1 Asia Pacific Immunochromogenic Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Immunochromogenic Kit Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Immunochromogenic Kit Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Immunochromogenic Kit Market Facts & Figures by Country
- 5.7.1 South America Immunochromogenic Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Immunochromogenic Kit Sales by Country (2021-2032)
- 5.7.3 South America Immunochromogenic Kit Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Immunochromogenic Kit Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Immunochromogenic Kit Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Immunochromogenic Kit Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Immunochromogenic Kit Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Immunochromogenic Kit Sales by Type (2021-2032)
- 6.1.1 Global Immunochromogenic Kit Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Immunochromogenic Kit Sales Market Share by Type (2021-2032)
- 6.2 Global Immunochromogenic Kit Revenue by Type (2021-2032)
- 6.2.1 Global Immunochromogenic Kit Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Immunochromogenic Kit Revenue Market Share by Type (2021-2032)
- 6.3 Global Immunochromogenic Kit Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Immunochromogenic Kit Sales by Application (2021-2032)
- 7.1.1 Global Immunochromogenic Kit Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Immunochromogenic Kit Sales Market Share by Application (2021-2032)
- 7.2 Global Immunochromogenic Kit Revenue by Application (2021-2032)
- 7.2.1 Global Immunochromogenic Kit Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Immunochromogenic Kit Revenue Market Share by Application (2021-2032)
- 7.3 Global Immunochromogenic Kit Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Immunochromogenic Kit Value Chain Analysis
- 8.1.1 Immunochromogenic Kit Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Immunochromogenic Kit Production Mode & Process
- 8.2 Immunochromogenic Kit Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Immunochromogenic Kit Distributors
- 8.2.3 Immunochromogenic Kit Customers
9 Global Immunochromogenic Kit Analyzing Market Dynamics
- 9.1 Immunochromogenic Kit Industry Trends
- 9.2 Immunochromogenic Kit Industry Drivers
- 9.3 Immunochromogenic Kit Industry Opportunities and Challenges
- 9.4 Immunochromogenic Kit Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst